Background Image
Table of Contents Table of Contents
Previous Page  48 / 124 Next Page
Information
Show Menu
Previous Page 48 / 124 Next Page
Page Background

48

2014 Annual Report

3. Registration Management of Medical Device Manufacturing Factories

Medical device importers may apply for registration letters proving the compliance

of overseas manufacturing factories with the regulation of R.O.C. Quality System

D o c ume n t a t i o n ( QS D ) . T h e

audit inspections for domestic

ma n u f a c t u r e r s a r e p r i ma r i l y

conducted on-site. Importers may

apply for on-site inspections of

overseas manufacturing factories.

By the end of 2013, there were

568 valid registration letters for

domestic medical device GMP, and

3,231registration letters for imported

medical device QSD (Table 4-2).

Section 3 Post-Market Quality Surveillance of Medical Devices

Status

For post-market quality and performance surveillance of medical devices, specific

items were chosen on the basis of risk factor evaluation each year. TFDA integrated the

resources from the local health bureaus to implement the surveillance program in order to

monitor the quality and performance of post- market medical devices.

Policy and Outcome

1. Post-Market Quality and Performance Surveillance of Medical Devices

(1) Risk factor evaluation for the medical devices under surveillance

The surveillance items are chosen based on the risk factors such as medical device

post-market adverse event reports and surveillance reports for defective items. National

samplings are performed for the specific items. The test results provide a complete

quality assessment of the products and prevent possible harm caused by poor quality

of medical devices, and can be used as reference for future policy making on product

quality management.

(2) Results for the post-market quality and performance surveillance

In 2013, a total of 199 samples were inspected for quality performance and package

labeling. There were 174 samples passing the quality performance qualification and the

qualification rate was 93.5% .There were 191 samples passing the package labeling

qualification and the qualification rate was 96%. The devices which failed the inspection

were sent to the local health bureaus to deal with in accordance with the law. The

results of the surveillance are shown in Table 4-3.

Table 4-2 Number of valid registrations for

medical device GMP/QSD

Valid registration letters for medical device

GMP/QSD

Year

Valid GMP

registration letters

Valid QSD

registration letters

2010

236

1,340

2011

486

2,777

2012

531

3,065

2013

568

3,213